KM Research Hub
← 返回论文库
待处理 入排:待复核 图源:待检查 入排置信度 0.00

A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed.

Jianxing He, Walter Weder, Ke-Neng Chen, Maximilian J Hochmair, Jin-Yuan Shih, Sung Yong Lee, Kang-Yun Lee, Viet Nhung Nguyen, Somcharoen Saeteng, Lunxu Liu, Ligang Xing, Nguyen Hoang Gia, Shuji Murakami, Yongtao Han, María Paz Saavedra, Seong Hoon Yoon, Carlos H A Teixeira, Carles Escriu, Alex Martinez-Martí, Collin M Blakely, Yasushi Yatabe, Sanja Dacic, Yuri Rukazenkov, Xiangning Huang, Anupriya Dayal, Jamie E Chaft, NeoADAURA Investigators

Future Oncol 22(23) 2747-2757

PMID42954342
PMCIDPMC13733581
DOI10.1080/14796694.2026.2739188
发表日期2026-10-29
入排依据:未可靠识别 OS/PFS/DFS/EFS/RFS/TTP、Kaplan-Meier、HR 或其他 time-to-event 结局,需复核。
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。